Jang KM. Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment. Yeungnam Univ J Med. 2020;37:13–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes. 2019;12:1047–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colclough K, Patel K. How do I diagnose Maturity Onset Diabetes of the Young in my patients? Clin Endocrinol (Oxf). 2022;97:436–47.

Article  PubMed  Google Scholar 

Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia. 2012;55:1265–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ovsyannikova AK, Rymar OD, Shakhtshneider EV, Klimontov VV, Koroleva EA, Myakina NE, et al. ABCC8-Related maturity-onset diabetes of the Young (MODY12): clinical features and treatment perspective. Diabetes Therapy. 2016;7:591–600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Colclough K, Gloyn AL, Pollin TI. Monogenic diabetes: a gateway to precision medicine in diabetes. J Clin Invest 2021;131.

Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 2011;343.

Timmers M, Dirinck E, Lauwers P, Wuyts W, De Block C. ABCC8 variants in MODY12: review of the literature and report of a case with severe complications. Diabetes Metab Res Rev 2021;37.

Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, et al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia. 2012;55:123–7.

Article  CAS  PubMed  Google Scholar 

Haghverdizadeh P, Sadat Haerian M, Haghverdizadeh P, Sadat Haerian B. ABCC8 genetic variants and risk of diabetes mellitus. Gene. 2014;545:198–204.

Article  CAS  Google Scholar 

Patch AM, Flanagan SE, Boustred C, Hattersley AT, Ellard S. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period. Diabetes Obes Metab. 2007;9:28–39.

Article  CAS  PubMed  Google Scholar 

Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest. 2005;115:2047–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kapoor RR, James C, Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab. 2009;5:101–12.

Article  CAS  PubMed  Google Scholar 

Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet. 2003;361:301–7.

Article  CAS  PubMed  Google Scholar 

Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, et al. Activating mutations in the ABCC8 gene in neonatal diabetes Mellitus. N Engl J Med. 2006;355:456–66.

Article  CAS  PubMed  Google Scholar 

Flanagan SE, Patch AM, Mackay DJG, Edghill EL, Gloyn AL, Robinson D, et al. Mutations in ATP-Sensitive K + Channel Genes Cause Transient Neonatal Diabetes and permanent diabetes in Childhood or Adulthood. Diabetes. 2007;56:1930–7.

Article  CAS  PubMed  Google Scholar 

Riveline JP, Rousseau E, Reznik Y, Fetita S, Philippe J, Dechaume A, et al. Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations. Diabetes Care. 2012;35:248–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flanagan SE, Dung VC, Houghton JAL, Franco E, De, Ngoc CTB, Damhuis A, et al. An ABCC8 nonsense mutation causing neonatal diabetes through altered transcript expression. J Clin Res Pediatr Endocrinol. 2017;9:260–4.

Article  PubMed  PubMed Central  Google Scholar 

Koufakis T, Sertedaki A, Tatsi EB, Trakatelli CM, Karras SN, Manthou E, et al. First Report of Diabetes phenotype due to a loss-of-function ABCC8 mutation previously known to cause congenital hyperinsulinism. Case Rep Genet. 2019;2019:1–5.

Google Scholar 

Karatojima M, Furuta H, Matsutani N, Matsuno S, Tamai M, Komiya K, et al. A family in which people with a heterozygous ABCC8 gene mutation (p.Lys1385Gln) have progressed from hyperinsulinemic hypoglycemia to hyperglycemia. J Diabetes. 2020;12:21–4.

Article  CAS  PubMed  Google Scholar 

Matsutani N, Furuta H, Matsuno S, Oku Y, Morita S, Uraki S, et al. Identification of a compound heterozygous inactivating ABCC8 gene mutation responsible for young-onset diabetes with exome sequencing. J Diabetes Investig. 2020;11:333–6.

Article  CAS  PubMed  Google Scholar 

Romanisio G, Salina A, Aloi C, Schiaffino MC, Virgone A, d’Annunzio G. A mild impairment of K + ATP channel function caused by two different ABCC8 defects in an Italian newborn. Acta Diabetol. 2018;55:201–3.

Article  CAS  PubMed  Google Scholar 

Snider KE, Becker S, Boyajian L, Shyng SL, MacMullen C, Hughes N, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab. 2013;98:E355–63.

Article  CAS  PubMed  Google Scholar 

Saint-Martin C, Zhou Q, Martin GM, Vaury C, Leroy G, Arnoux J, ‐B., et al. Monoallelic ABCC8 mutations are a common cause of diazoxide‐unresponsive diffuse form of congenital hyperinsulinism. Clin Genet. 2015;87:448–54.

Article  CAS  PubMed  Google Scholar 

Öçal G, Flanagan SE, Hacihamdioğlu B, Berberoğlu M, Şiklar Z, Ellard S et al. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell. J Pediatr Endocrinol Metab 2011;24.

MacMullen CM, Zhou Q, Snider KE, Tewson PH, Becker SA, Aziz AR, et al. Diazoxide-unresponsive congenital hyperinsulinism in Children with Dominant mutations of the β-Cell sulfonylurea receptor SUR1. Diabetes. 2011;60:1797–804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banerjee I, Skae M, Flanagan SE, Rigby L, Patel L, Didi M, et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol. 2011;164:733–40.

Article  CAS  PubMed  Google Scholar 

Salomon-Estebanez M, Flanagan SE, Ellard S, Rigby L, Bowden L, Mohamed Z, et al. Conservatively treated congenital hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. Orphanet J Rare Dis. 2016;11:163.

Article  PubMed  PubMed Central  Google Scholar 

Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko HL, Rahier J et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest 2000;897–906.

Flanagan SE, Kapoor RR, Banerjee I, Hall C, Smith VV, Hussain K et al. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia. Clin Genet 2011;582–7.

Yan FF, Lin YW, MacMullen C, Ganguly A, Stanley CA, Shyng SL. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K + channels: identification and rescue. Diabetes 2007;2339–48.

Sandal T, Laborie LB, Brusgaard K, Eide SA, Christesen HBT, Søvik O et al. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clin Genet 2009;440–8.

Gussinyer M, Clemente M, Cebrián R, Yeste D, Albisu M, Carrascosa A. Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene. Diabetes Care. 2008;31:1257–9.

Article  CAS  PubMed  Google Scholar 

Işık E, Demirbilek H, Houghton JA, Ellard S, Flanagan SE, Hussain K. Congenital hyperinsulinism and evolution to Sulfonylurearesponsive Diabetes later in Life due to a Novel homozygous p.L171F ABCC8 mutation. J Clin Res Pediatr Endocrinol. 2019;11:82–7.

Article  PubMed  PubMed Central  Google Scholar 

Abdulhadi-Atwan M, Bushman J, Tornovsky-Babaey S, Perry A, Abu-Libdeh A, Glaser B, et al. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence. Diabetes. 2008;57:1935–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harel S, Cohen ASA, Hussain K, Flanagan SE, Schlade-Bartusiak K, Patel M, et al. Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture. J Pediatr Endocrinol Metab. 2015;28:345–51.

CAS  PubMed